Evidence map›Paper›PMID 32419932›Full record

SynthesisEuropean journal of hospital pharmacy : science and practice2020

Evaluation of a clinical pharmacist consultation service for patients with infectious diseases in China: a systematic review and meta-analysis.

Jiaxing Zhang, Xiaosi Li, Juan Xie, Wenyi Zheng

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in European journal of hospital pharmacy : science and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jiaxing ZhangDepartment of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.
Xiaosi LiDepartment of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.
Juan XieDepartment of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.
Wenyi ZhengExperimental Cancer Medicine, Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Guizhou Provincial People's Hospital · CNKarolinska Institutet · SETibet Autonomous Region People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Since antibiotic resistance has become a global public health issue, a clinical pharmacist consultation service has been established in China. Objectives: To clarify the role of the clinical pharmacist consultation service in the management of infectious diseases (ID). Methods: Medline, Embase, Cochrane Library, Chinese National Knowledge Infrastructure, Chinese Biomedical Database, Vip Database and Wanfang Database were searched for studies meeting predefined inclusion criteria. The pooled acceptance rate of consultation (ARC) and effective rate of patients treated with the acceptance of pharmacists' suggestions (ERA) were then calculated. Results: Fifty studies (involving 8616 patients and 8828 consultations) from 17 different provinces in China were included. The pooled ARC and ERA were 93.13% (95% CI 90.62% to 95.00%) and 93.60% (95% CI 91.99% to 95.24%), respectively. Adopting pharmacists' suggestions can significantly improve the prognosis of patients with ID with a risk ratio of 2.08 (95% CI 1.41 to 3.06). Factors such as study time, characteristics of the research institution and patients have important influences on ARC. Conclusion: Prospective cohort studies with better methodology are needed, although a series of uncontrolled studies has shown that the service has excellent acceptance and improves the effectiveness of treatment for ID.

Indexed as

Anti-Bacterial AgentsChinaCommunicable DiseasesConsultantsDrug Resistance, BacterialHumansPharmacistsPharmacy Service, HospitalProfessional RolePrognosisAnti-Bacterial Agentscase seriesclinical pharmacyconsultation serviceinfectious diseasesmeta-analysissystematic review

Identifiers

PMID32419932
PMCPMC7223343
OpenAlexW2952891532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.